CK-18 levels are elevated in the presence of necrosis and apoptosis in liver disease [28] with high levels of CK-18 being present in patients with non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and chronic hepatitis C (CHC) [27, 28]. This evidence concerns the gene KRT18 and metabolic dysfunction-associated steatohepatitis.